MICAL2, which was significantly upregulated in our PTvs.N dataset, has been identified as one of the most significantly upregulated genes in smoking-induced lung cancer43 and has been associated with prostate cancer progression44 as well as EMT, cancer growth and invasion45, but has not been implicated with head and neck cancer, yet. Here, MICAL2 is linked to prostate cancer.